Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism

被引:1
|
作者
Hald, Erin M. [1 ,2 ]
Braekkan, Sigrid K. [1 ]
Vik, Anders [1 ,2 ]
Brodin, Ellen E. [1 ,2 ]
Hansen, John-Bjarne [1 ,2 ]
机构
[1] Univ Tromso, Dept Clin Med, Hematol Res Grp HERG, N-9037 Tromso, Norway
[2] Univ Hosp N Norway, Div Internal Med, Tromso, Norway
关键词
Venous; Thromboembolism; Postprandial lipemia; Risk factors; Cardiovascular disease; HIGH-DENSITY-LIPOPROTEIN; CARDIOVASCULAR RISK-FACTORS; SUBCLINICAL ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; ELDERLY SURVIVORS; HORMONE-THERAPY; HEART-DISEASE; THROMBOSIS; TRIGLYCERIDES; CHOLESTEROL;
D O I
10.1016/j.jacl.2012.06.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Patients with arterial cardiovascular disease have increased postprandial lipemia, and plasma levels of postprandial remnants are related to the progression of atherosclerosis. Studies have shown that patients with unprovoked venous thromboembolism have increased risk of arterial cardiovascular disease. OBJECTIVE: To investigate whether patients with a history of unprovoked venous thromboembolism have increased postprandial lipemia. METHODS: A population-based case control study was performed in 20 patients with a history of unprovoked venous thromboembolism and 20 age- and gender-matched healthy controls. Participants were subjected to a standard fat tolerance test (1 g/kilo body weight) with subsequent blood sampling every second hour for 8 hours. Lipids were measured by traditional methods and lipoprotein subclasses by proton nuclear magnetic resonance. RESULTS: Fasting lipids and lipoprotein subclasses did not differ between groups. The postprandial lipemia, assessed by the incremental area under the triglyceride curve, was not different in venous thromboembolism patients and healthy controls (5.0 +/- 3.6 mmol/L*h vs 5.3 +/- 4.4 mmol/L*h, P = .81). Similarly, the distribution and size of the lipoprotein subclasses obtained 4 hours postprandially did not differ between groups. CONCLUSION: Patients with a history of unprovoked venous thromboembolism had similar lipoprotein subclasses size, distribution, and postprandial lipemia as healthy controls. Our findings indicate that postprandial lipemia is not a link between unprovoked venous thromboembolism and arterial cardiovascular disease. C) 2013 National Lipid Association. All rights reserved.
引用
收藏
页码:48 / 55
页数:8
相关论文
共 50 条
  • [31] SCREENING FOR MALIGNANCY WITH PET/CT SCAN IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM
    Sacre, K.
    Chauchard, M.
    Rouzet, F.
    Papo, T.
    ANNALS OF ONCOLOGY, 2014, 25
  • [32] Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated
    Clive Kearon
    Journal of Thrombosis and Thrombolysis, 2011, 31 : 295 - 300
  • [33] Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea
    Hwang, Hun Gyu
    Kim, Myung Shin
    Lim, Gune Il
    Choi, Won-Il
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [34] Screening for Occult Cancer in Unprovoked Venous Thromboembolism
    Carrier, Marc
    Lazo-Langner, Alejandro
    Shivakumar, Sudeep
    Tagalakis, Vicky
    Zarychanski, Ryan
    Solymoss, Susan
    Routhier, Nathalie
    Douketis, James
    Danovitch, Kim
    Lee, Agnes Y.
    Le Gal, Gregoire
    Wells, Philip S.
    Corsi, Daniel J.
    Ramsay, Timothy
    Coyle, Doug
    Chagnon, Isabelle
    Kassam, Zahra
    Tao, Hardy
    Rodger, Marc A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 697 - 704
  • [35] A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)
    Franco Moreno, A. I.
    Garcia Navarro, M. J.
    Ortiz Sanchez, J.
    Martin Diaz, R. M.
    Madronal Cerezo, E.
    de Ancos Aracil, C. L.
    Cabello Clotet, N.
    Perales Fraile, I.
    Gimeno Garcia, S.
    Montero Hernandez, C.
    Zapatero Gaviria, A.
    Ruiz Giardin, J. M.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 29 : 59 - 64
  • [36] The utility of hereditary thrombophilia testing among patients with unprovoked venous thromboembolism
    Freites, Cristina Olivo
    Naymagon, Leonard
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (02) : 393 - 398
  • [37] Cancer Screening in Unprovoked Venous Thromboembolism REPLY
    Carrier, Marc
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2475 - 2475
  • [38] Stopping anticoagulation in a woman with unprovoked venous thromboembolism
    Khan, Faizan
    Le Gal, Gregoire
    Rodger, Marc A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (35) : E1112 - E1114
  • [39] Extending anticoagulation treatment for unprovoked venous thromboembolism
    Heneghan, Carl
    Aronson, Jeffrey
    BMJ EVIDENCE-BASED MEDICINE, 2020, 25 (05) : 184 - +
  • [40] Venous thromboembolism in patients with previous cancer: a marker of tumor?
    Reus, S
    Azkarreta, IL
    Murcia, J
    Manso, MI
    MEDICINA CLINICA, 2003, 120 (04): : 156 - 156